(Q37956954)

25 August 2017

Sex-related differences in pharmacokinetics and pharmacodynamics of anti-hypertensive drugs (English)

1 reference

25 August 2017

1 reference

1 reference

Koichi Ueno

1

1 reference

PubMed ID

22089536

25 August 2017

Hiromi Sato

series ordinal

2

1 reference

25 August 2017

17 November 2011

1 reference

25 August 2017

Hypertension Research

1 reference

25 August 2017

35

1 reference

25 August 2017

3

1 reference

25 August 2017

245-250

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2011.189

25 August 2017

0 references

cites work

Gender differences in pharmacological response

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Biologic and molecular mechanisms for sex differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

The effect of gender on the pharmacokinetics of verapamil and norverapamil in human.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Population analyses of amlodipine in patients living in the community and patients living in nursing homes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Sexual dimorphism in angiotensin II-induced hypertension and vascular alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Sex differences in the development of angiotensin II-induced hypertension in conscious mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Androgen regulation of rat renal angiotensinogen messenger RNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Sex differences in the pressor response to angiotensin II when the endogenous renin-angiotensin system is blocked

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Estrogen receptor-alpha mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Cardiovascular outcome of an angiotensin II receptor blocker, candesartan, in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Cardiovascular alteration and treatment of hypertension: do men and women differ?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Gender differences in angiotensin-converting enzyme (ACE) activity and inhibition by enalaprilat in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Gender difference in the response to an angiotensin-converting enzyme inhibitor and a diuretic in hypertensive patients of African descent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Angiotensin-converting enzyme inhibition increases basal vascular tissue plasminogen activator release in women but not in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Determinants of steady-state torasemide pharmacokinetics: impact of pharmacogenetic factors, gender and angiotensin II receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Effects of gender on the pharmacokinetics of drugs secreted by the renal organic anions transport systems in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

The influence of sex on pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Modulation of metoprolol pharmacokinetics and hemodynamics by diphenhydramine coadministration during exercise testing in healthy premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Toward optimal treatment in women: the effect of sex on metoprolol-diphenhydramine interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Influence of carvedilol on serum digoxin levels in heart failure: is there any gender difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

How important are gender differences in pharmacokinetics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Pharmacokinetic characterization of transcellular transport and drug interaction of digoxin in Caco-2 cell monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Interaction of digoxin with antihypertensive drugs via MDR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Sex is a major determinant of CYP3A4 expression in human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

Sex is a major determinant of CYP3A4 expression in human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

7 January 2021

Age but not gender selectively affects expression of individual cytochrome P450 proteins in human liver

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

7 January 2021

Effects of age and gender on in vitro properties of human liver microsomal monooxygenases

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

7 January 2021

Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

7 January 2021

In vivo comparison of putative probes of CYP3A4/5 activity: erythromycin, dextromethorphan, and verapamil

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

7 January 2021

Multicenter placebo-controlled comparison of amlodipine and atenolol in mild to moderate hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

7 January 2021

Comparison of amlodipine and verapamil in the treatment of mild to moderate hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

7 January 2021

Predictors of blood pressure response to angiotensin receptor blocker/diuretic combination therapy: a secondary analysis of the irbesartan/hydrochlorothiazide blood pressure reductions in diverse patient populations (INCLUSIVE) study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

7 January 2021

Gender differences in the renal response to renin-angiotensin system blockade

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

7 January 2021

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

7 January 2021

The anti-ischemic effect of metoprolol in patients with chronic angina pectoris is gender-specific

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

7 January 2021

Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

7 January 2021

Propranolol metabolism in normal subjects: association with sex steroid hormones

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.189

7 January 2021

Identifiers

DOI

10.1038/HR.2011.189

1 reference

25 August 2017

1 reference

PubMed ID

22089536